NCT01307982

Brief Summary

This trial is a randomized controlled trial of two standard anti-reflux procedures, Nissen fundoplication versus gastrojejunal feeding tubes (GJ tubes), in children and adolescents with functional and intellectual impairment who have gastrostomy feeding tubes and medically refractory or severe gastroesophageal reflux disease (GERD). This is a pilot study to establish feasibility before initiating a multi-centered study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2011

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 18, 2011

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 3, 2011

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2013

Completed
Last Updated

October 21, 2013

Status Verified

October 1, 2013

Enrollment Period

2.7 years

First QC Date

February 18, 2011

Last Update Submit

October 17, 2013

Conditions

Keywords

Gastroesophageal RefluxNervous System DiseasesFundoplicationEnteral Nutrition

Outcome Measures

Primary Outcomes (1)

  • GERD-related hospitalization and ED visits

    Parental interviews and chart reviews will be used to record all health care encounters. Each encounter will be classified as either GERD-related or not. GERD-related hospitalizations and ED visits will be further classified as; diagnostic testing, procedural problems, likely aspiration pneumonia (AP or bacterial pneumonia), respiratory distress of other etiology, or death from any cause.

    12 months

Secondary Outcomes (11)

  • Health Related Quality of Life

    12 months

  • Total length of stay

    12 months

  • Complications from treatment

    12 months

  • Complications from failure of treatment

    12 months

  • Mortality

    12 months

  • +6 more secondary outcomes

Study Arms (2)

Fundoplication

ACTIVE COMPARATOR

During fundoplication surgery, the upper curve of the stomach (the fundus) is wrapped around the esophagus and sewn into place so that the lower portion of the esophagus passes through a small tunnel of stomach muscle. This surgery strengthens the valve between the esophagus and stomach (lower esophageal sphincter), which stops acid from backing up into the esophagus as easily.

Procedure: Fundoplication

Gastrojejunal (GJ) feeding tube

ACTIVE COMPARATOR

Gastrojejunal (GJ) tube placement is an image guided technique in which a special soft feeding catheter is placed through an existing hole in the stomach (gastrostomy) into the small bowel (jejunum).

Procedure: Gastrojejunal (GJ) feeding tube

Interventions

During fundoplication surgery, the upper curve of the stomach (the fundus) is wrapped around the esophagus and sewn into place so that the lower portion of the esophagus passes through a small tunnel of stomach muscle. This surgery strengthens the valve between the esophagus and stomach (lower esophageal sphincter), which stops acid from backing up into the esophagus as easily.

Also known as: Nissen Fundoplication
Fundoplication

Gastrojejunal (GJ) tube placement is an image guided technique in which a special soft feeding catheter is placed through an existing hole in the stomach (gastrostomy) into the small bowel (jejunum).

Also known as: GJ tube
Gastrojejunal (GJ) feeding tube

Eligibility Criteria

Age6 Months - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • patient is between 6 months and 18 years of age; AND
  • patient has functional impairment classified by either gross motor functional classification of 3, 4 or 5 OR impaired function in walking, crawling/standing, rolling/sitting, arm use, hand use, ability to hold head up; AND
  • patient has a gastrostomy; AND
  • patient has intolerance of feedings or other complications attributed to GERD as defined below; AND
  • patient has a positive GERD diagnostic evaluation as define below:
  • GERD diagnostic evaluation will include the following investigations;
  • endoscopy and biopsy for visual assessment and histology of the esophageal mucosa
  • pH study and/or multichannel intraluminal impedance (MII) probe to detect and quantify gastroesophageal reflux
  • GER demonstrated by:
  • Reflux Esophagitis: Endoscopic appearance of mucosal breaks in the distal esophagus with or without pathologist diagnosis based on one or more biopsy histologic features of: inflammatory cellular infiltrate, basal cell hyperplasia, elongation of the vascular papillae AND no infectious microorganisms and \< 15 eosinophils per high power field; OR
  • pH OR pH/multichannel intraluminal impedance(MII) probe evidence of pathologic GER:
  • pH probe: acid reflux index \> 7 % OR
  • pH/MII reflux symptom-associated acid or non-acid volume associated reflux events;
  • Upper GI will only be used to determine normal anatomy; AND
  • patient has either medically refractory GERD or severe GERD as defined below:
  • +12 more criteria

You may not qualify if:

  • Upper GI findings that would mandate a fundoplication including: hiatal hernia, esophageal stricture, Barret's esophagus; OR
  • Upper GI findings show uncorrected distal gastrointestinal obstruction including: gastric outlet obstruction, duodenal obstruction, malrotation; OR
  • Upper GI demonstrates structural foregut abnormalities that preclude a fundoplication including: microgastria, short esophagus, high anesthetic risk; OR
  • Diagnosis or history of congenital diaphragmatic hernia, esophageal atresia, chronic intestinal pseudoobstruction; OR
  • Endoscopy and biopsy demonstrates esophagitis from causes other than GER including: eosinophilic esophagitis, candida esophagitis, viral esophagitis); OR
  • Rapidly changing or indeterminate neurological including either a deteriorating neurological condition such as rapid loss of developmental milestones or improving, such as rapid recovery following severe neurological insult; OR
  • Patient has unacceptable general anesthetic risk; OR
  • A previous Nissen fundoplication; OR
  • Feeds delivered by GJ/NJ at the time of enrollment occurring for greater than 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Primary Children's Medical Center

Salt Lake City, Utah, 84113, United States

Location

MeSH Terms

Conditions

Gastroesophageal RefluxNervous System Diseases

Interventions

FundoplicationEnteral Nutrition

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Digestive System Surgical ProceduresSurgical Procedures, OperativeFeeding MethodsTherapeuticsNutritional SupportNutrition Therapy

Study Officials

  • Raj Srivastava, MD, MPH

    University of Utah

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Raj Srivastava, MD, MPH

Study Record Dates

First Submitted

February 18, 2011

First Posted

March 3, 2011

Study Start

January 1, 2011

Primary Completion

September 1, 2013

Study Completion

September 1, 2013

Last Updated

October 21, 2013

Record last verified: 2013-10

Locations